The Office of Cooperative Research has struck a deal with a Science Park biotech firm to distribute new reagents created during the course of University research. Recombinant Technologies, founded by associate research scientist Pazhani Sundaram, Ph.D., of the School of Public Health, will work with the University to identify commercially viable reagents and negotiate their distribution to researchers.
Previous Article
Dr. Mel’s doctors
Next Article
Farewell to ‘The Giff’